Segui
emma buzzigoli
emma buzzigoli
Isituto di Fisiologia Clinica, CNR
Email verificata su ifc.cnr.it
Titolo
Citata da
Citata da
Anno
Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease
M Gaggini, M Morelli, E Buzzigoli, RA DeFronzo, E Bugianesi, ...
Nutrients 5 (5), 1544-1560, 2013
10082013
Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects
A Gastaldelli, K Cusi, M Pettiti, J Hardies, Y Miyazaki, R Berria, ...
Gastroenterology 133 (2), 496-506, 2007
7372007
Visceral fat in hypertension: influence on insulin resistance and β-cell function
AM Sironi, A Gastaldelli, A Mari, D Ciociaro, V Postano, E Buzzigoli, ...
Hypertension 44 (2), 127-133, 2004
3692004
Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance
M Gaggini, F Carli, C Rosso, E Buzzigoli, M Marietti, V Della Latta, ...
Hepatology 67 (1), 145-158, 2018
3532018
Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein
G Basta, AM Sironi, G Lazzerini, S Del Turco, E Buzzigoli, A Casolaro, ...
The Journal of Clinical Endocrinology & Metabolism 91 (11), 4628-4634, 2006
2642006
Gut to brain interaction in Autism Spectrum Disorders: a randomized controlled trial on the role of probiotics on clinical, biochemical and neurophysiological parameters
E Santocchi, L Guiducci, F Fulceri, L Billeci, E Buzzigoli, F Apicella, ...
BMC psychiatry 16, 1-16, 2016
2032016
Impact of increased visceral and cardiac fat on cardiometabolic risk and disease
AM Sironi, R Petz, D De Marchi, E Buzzigoli, D Ciociaro, V Positano, ...
Diabetic Medicine 29 (5), 622-627, 2012
1572012
Separate contribution of diabetes, total fat mass, and fat topography to glucose production, gluconeogenesis, and glycogenolysis
A Gastaldelli, Y Miyazaki, M Pettiti, E Buzzigoli, S Mahankali, E Ferrannini, ...
The Journal of Clinical Endocrinology & Metabolism 89 (8), 3914-3921, 2004
1382004
The effect of pioglitazone on the liver: role of adiponectin
A Gastaldelli, Y Miyazaki, A Mahankali, R Berria, M Pettiti, E Buzzigoli, ...
Diabetes care 29 (10), 2275-2281, 2006
1012006
Quantification of liver glucose metabolism by positron emission tomography: validation study in pigs
P Iozzo, MJ Jarvisalo, J Kiss, R Borra, GA Naum, A Viljanen, T Viljanen, ...
Gastroenterology 132 (2), 531-542, 2007
822007
Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease
C Rosso, L Mezzabotta, M Gaggini, F Salomone, R Gambino, A Marengo, ...
Hepatology 63 (1), 107-116, 2016
812016
Effects of adding exercise to a 16-week very low-calorie diet in obese, insulin-dependent type 2 diabetes mellitus patients
M Snel, A Gastaldelli, DM Ouwens, MKC Hesselink, G Schaart, ...
The Journal of Clinical Endocrinology & Metabolism 97 (7), 2512-2520, 2012
802012
Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD
I Pierantonelli, C Rychlicki, L Agostinelli, DM Giordano, M Gaggini, ...
Scientific reports 7 (1), 12200, 2017
79*2017
Glucokinase links Krüppel‐like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver disease
LP Bechmann, A Gastaldelli, D Vetter, GL Patman, L Pascoe, ...
Hepatology 55 (4), 1083-1093, 2012
762012
Effect of pioglitazone on the metabolic and hormonal response to a mixed meal in type II diabetes
A Gastaldelli, A Casolaro, M Pettiti, M Nannipieri, D Ciociaro, S Frascerra, ...
Clinical Pharmacology & Therapeutics 81 (2), 205-212, 2007
732007
Visceral fat and beta cell function in non-diabetic humans
A Gastaldelli, AM Sironi, D Ciociaro, V Positano, E Buzzigoli, D Giannessi, ...
Diabetologia 48, 2090-2096, 2005
642005
18F-FDG assessment of glucose disposal and production rates during fasting and insulin stimulation: a validation study
P Iozzo, A Gastaldelli, MJ Järvisalo, J Kiss, R Borra, E Buzzigoli, ...
Journal of nuclear medicine 47 (6), 1016-1022, 2006
562006
40th EASD Annual Meeting of the European Association for the Study of Diabetes: Munich, Germany, 5–9 September 2004
M Veitenhansl, K Stegner, FX Hierl, C Dieterle, H Feldmeier, B Gutt, ...
Diabetologia 47, A1-A464, 2004
502004
Decreased whole body lipolysis as a mechanism of the lipid-lowering effect of pioglitazone in type 2 diabetic patients
A Gastaldelli, A Casolaro, D Ciociaro, S Frascerra, M Nannipieri, ...
American Journal of Physiology-Endocrinology and Metabolism 297 (1), E225-E230, 2009
352009
Biomonitoring of Bis (2-ethylhexyl) phthalate (DEHP) in Italian children and adolescents: Data from LIFE PERSUADED project
S Tait, F Carli, L Busani, E Buzzigoli, V Della Latta, A Deodati, E Fabbrizi, ...
Environmental research 185, 109428, 2020
312020
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20